Beginning today, American hospitals can purchase Veklury (remdesivir) directly from the drug’s distributor, the Department of Health and Human Services announced today.

Due to limited supply, the federal government previously allocated and distributed the antiviral drug, authorized for emergency use to treat hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.

Gilead Sciences, which makes the drug, said it is “now meeting real-time demand for Veklury in the United States and anticipates meeting global demand for Veklury in October, even in the event of potential future surges of COVID-19.”

To ensure stable management of drug supply in the near term, AmerisourceBergen will continue to serve as the sole U.S. distributor through the end of this year and will sell the product directly to hospitals, the company said. It said hospitals “will control the quantity of Veklury that they order, enabling them to have ample, predictable supply of Veklury in advance of any anticipated increase in COVID-19 incidence.”

Related News Articles

Perspective
We’ve been discussing for months how hospitals and health systems are contending with the worst financial crisis in their history as they continue to serve on…
Headline
The Centers for Medicare & Medicaid Services yesterday issued a final rule updating the home health prospective payment system for calendar year 2021.…
Headline
The Federal Reserve Board today reduced the minimum loan size for three Main Street Lending Program facilities from $250,000 to $100,000 and adjusted…
Headline
“The COVID-19 pandemic has proved that crisis tends to be a driver of innovation,” writes Jonathan Bandel, vice president of strategy and innovation for New…
Headline
The Food and Drug Administration Wednesday updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient…
Headline
Over 10,000 eligible nursing homes, or 76% of the field, will receive a portion of $333 million in COVID-19 Provider Relief Funds for meeting infection control…